1. Home
  2. MNDR vs EVOK Comparison

MNDR vs EVOK Comparison

Compare MNDR & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNDR
  • EVOK
  • Stock Information
  • Founded
  • MNDR 2016
  • EVOK 2007
  • Country
  • MNDR Singapore
  • EVOK United States
  • Employees
  • MNDR N/A
  • EVOK N/A
  • Industry
  • MNDR
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • MNDR
  • EVOK Health Care
  • Exchange
  • MNDR Nasdaq
  • EVOK Nasdaq
  • Market Cap
  • MNDR 6.8M
  • EVOK 7.7M
  • IPO Year
  • MNDR 2024
  • EVOK 2013
  • Fundamental
  • Price
  • MNDR $1.07
  • EVOK $4.43
  • Analyst Decision
  • MNDR
  • EVOK
  • Analyst Count
  • MNDR 0
  • EVOK 0
  • Target Price
  • MNDR N/A
  • EVOK N/A
  • AVG Volume (30 Days)
  • MNDR 74.1K
  • EVOK 7.2M
  • Earning Date
  • MNDR 06-16-2025
  • EVOK 08-12-2025
  • Dividend Yield
  • MNDR N/A
  • EVOK N/A
  • EPS Growth
  • MNDR N/A
  • EVOK N/A
  • EPS
  • MNDR N/A
  • EVOK N/A
  • Revenue
  • MNDR $11,600,567.00
  • EVOK $11,594,083.00
  • Revenue This Year
  • MNDR $188,831.77
  • EVOK $57.82
  • Revenue Next Year
  • MNDR $76.44
  • EVOK $59.12
  • P/E Ratio
  • MNDR N/A
  • EVOK N/A
  • Revenue Growth
  • MNDR 0.61
  • EVOK 89.89
  • 52 Week Low
  • MNDR $1.04
  • EVOK $1.94
  • 52 Week High
  • MNDR $9.52
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • MNDR N/A
  • EVOK 53.72
  • Support Level
  • MNDR N/A
  • EVOK $4.26
  • Resistance Level
  • MNDR N/A
  • EVOK $4.73
  • Average True Range (ATR)
  • MNDR 0.00
  • EVOK 0.73
  • MACD
  • MNDR 0.00
  • EVOK -0.07
  • Stochastic Oscillator
  • MNDR 0.00
  • EVOK 25.95

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: